PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30344416-6	2018	P32 deletion, an NS5A RAS, has been gradually noticed in patients with DCV/ASV failure.	daclatasvir	71-74	inhibitor of growth family member 2	Homo sapiens	0-3	
31858513-1	2020	NS5A-P32 deletion (P32del) is a resistance-associated amino acid change that has recently gained popularity in direct-acting antiviral treatment for chronic hepatitis C. Although not yet detected in naive patients, it appears in 5 to 10% of hepatitis C genotype 1b patients who fail to respond to daclatasvir/asunaprevir and sofosbuvir/ledipasvir treatments.	daclatasvir	297-308	inhibitor of growth family member 2	Homo sapiens	5-8	
31846553-7	2020	RESULTS: Twenty of 43 (46.5%) daclatasvir+asunaprevir (DCV+ASV)-treated patients with virologic failure had no RASs at baseline, 3 (15%) acquired P32 deletion RASs.	daclatasvir	30-41	inhibitor of growth family member 2	Homo sapiens	146-149